Related Experiment Video
Updated: Mar 13, 2026

10:28
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
16.4K
Tattooing as a Symptom of Impulse Control Disorder in a Parkinsonian Patient With Pramipexole
David Maltête1, Floriane Le Goff, Gulden Ozel
1Department of Neurology Rouen University Hospital and University of Rouen and INSERM U1073 Rouen Faculty of Medicine Rouen, France Department of Neurology Rouen University Hospital and University of Rouen Rouen, France Department of Neurology Rouen University Hospital and University of Rouen Rouen, France romain.lefaucheur@chu-rouen.fr.
Journal of Clinical Psychopharmacology
|November 3, 2016
Abstract
No abstract available in PubMed .
More Related Videos
Related Concept Videos
Parkinson's Disease: Treatment
1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Parkinson's Disease: Overview
2.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K

